Reports Indicate Intervention to Delay or Exclude Measles Deaths from CDC Tallies
Quick Brief
Recent reports indicate that intervention by officials, including the new CDC director appointed by Trump, led to a delay or exclusion of measles-related deaths from official CDC tallies. Meanwhile, investigations involving specific cases, such as in Pennsylvania and Lancaster, are underway.
What Happened?
According to multiple reports, officials intervened regarding the inclusion of measles-related fatalities in the official Centers for Disease Control and Prevention (CDC) counts. Sources indicate that Kennedy asked to remove a Pennsylvania measles death from the tally, while the newly appointed CDC director ordered a delay in counting two measles-related deaths. Concurrently, local coroners are investigating related cases, including that of a child with measles in Lancaster.
Why It Matters
The transparency and accuracy of federal health data are critical during public health concerns like measles outbreaks. Allegations of political or administrative interference in the reporting of mortality statistics undermine public trust in official health agencies and data.
Key Facts
- Reports indicate intervention to prevent or delay the inclusion of two measles-related deaths in the CDC tally.
- Sources state that a request was made to remove a Pennsylvania measles death from the official counts.
- The newly appointed CDC director under Trump ordered a delay in counting two measles-related deaths.
- The Lancaster Coroner is actively investigating the death of a child with measles.
Compiled from 1 outlet
Related Stories
Roche to Expand Testing Capacity Amid Congo Ebola Outbreak
Roche Holding AG is deploying new laboratory equipment to the epicenter of the Democratic Republic of Congo's Ebola epidemic. The move comes as health authorities face ongoing challenges in containing a virus that has repeatedly outpaced the local response. The expansion aims to bolster diagnostic capabilities in the heavily affected Ituri region.
Psilocybin Found to Prevent Chemotherapy-Induced Nerve Damage in Preclinical Models
Recent research reveals that psilocybin may protect against a common and debilitating side effect of cancer treatment. Preclinical models demonstrate that the compound can prevent nerve damage and associated symptoms caused by chemotherapy. This discovery highlights potential new therapeutic applications for the psychedelic substance.
Diminishing HIV Stigma and Shifting Behaviors Drive Rising STI Rates Among Youth in Keralam
Health officials in Keralam note a steady rise in young people seeking treatment for sexually transmitted infections at district centers. Experts attribute this trend to a decreasing fear of HIV and shifting sexual behaviors among the youth. The focus on these rising risks coincides with World Sexual Health Day.
Reports Surface That RFK Jr. Ordered Deletion of Measles Deaths as CDC Continues Secret Tracking
Recent reports indicate that RFK Jr. requested the removal of a Pennsylvania measles death from the CDC's official tallies. Meanwhile, sources suggest the agency continues to track these fatalities in secret. The situation has drawn considerable public attention and commentary regarding public health transparency.